drugset / Trial / NCT06801522

Adrenaline Nasal Pack vs Xylometazoline Nasal Drops During Nasotracheal Intubation

NCT06801522

Phase 2/3 Recruiting 70 enrolled Shaheed Mohtarma Benazir Bhutto Institue of Trauma
RandomizedParallel-groupSingle-blindPrevention

Summary

The goal of this trial is to compare efficacy of xylometazoline nasal drops and adrenaline nasal pack in participants undergoing elective oromaxillofacial surgeries. The main question aim to answer is xylometazoline nasal drops better than adrenaline nasal packing in terms of nasal bleeding during nasotracheal intubation. Researchers are comparing 2 groups of participants. Participants in group Xylometazoline are receiving 0.1% xylometaxoline nasal drops. Participants in group Adrenaline are receiving adrenaline nasal packing.

Timeline

Start
2024-12-01
Primary completion
2025-03
Completion
2025-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Epinephrine Other / unclassified Intranasal
Subject Xylometazoline Small molecule 0.1 % Intranasal

Indications

No indication recorded.